Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer.

NCT06642857 · clinicaltrials.gov ↗

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Advanced Gastric Carcinoma
Advanced Gastroesophageal Junction Adenocarcinoma

Interventions

OTHER: Peripheral blood, tougue coating, saliva, and feces

Sponsor

Xiangdong Cheng